APIs per la ricerca e le impurità

7-Chloro-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid ethyl ester is a synthetic compound that has not been evaluated in humans. Studies have shown that the drug can be hydrolyzed to 7-chloro-6-fluoroquinoline 1,1′-(ethylenedioxy)bis(ethane), which is an impurity of norfloxacin. The ethyl esters of 7-chloroquinoline are also known to condense with formaldehyde and hydrolyze to 7-chloroquinolinic acid. This product may contain solvents such as acetone, chloroform, and alcohols that are used during the synthesis process. Decarboxylation of the drug occurs when it is heated at high temperatures in the presence of a catalyst, such as pyridine or sodium methoxide. It decarboxyl

CAS No. 78216-92-9 is a synthetic compound that can be used as an impurity standard, custom synthesis, drug product, or a reference material. It is used in the research and development of new drugs and for the production of active pharmaceutical ingredients (API) and drug products. CAS No. 78216-92-9 also has been shown to have pharmacological properties as a metabolite. It is a metabolite of ethyl p-amino benzoate in humans and other mammals. The chemical is soluble in water, methanol, ethanol, benzene, acetone, chloroform, ether, and acetonitrile. The solubility of CAS No. 78216-92-9 in water at 37°C (98.6°F) is 2 g/L; at 20°C (68°F) - 1 g/L; at 0°C (32°F) - 0.2 g

Ascolactone is a natural compound with potent anticancer properties. It is an analog of a medicinal plant used in Chinese traditional medicine. Ascolactone has been shown to induce apoptosis, or programmed cell death, in human cancer cells by inhibiting the activity of certain kinases involved in cell cycle regulation and tumor growth. Ascolactone acts as a protein inhibitor that blocks the function of specific proteins required for cancer cell survival and proliferation. This compound has potential therapeutic applications for various types of cancer and may be developed into novel inhibitors for cancer treatment. Ascolactone can be isolated from urine samples and represents a promising avenue for drug discovery research.

Please enquire for more information about 3,4-Dihydro naratriptan oxalate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Lincomycin impurity B is a chemical substance which is the result of the metabolism of lincomycin. It is found in the urine and feces of patients who have taken lincomycin orally. Lincomycin impurity B has been detected in various commercial formulations of lincomycin, but its concentration varies with different batches. The HPLC standard purity for lincomycin impurity B is up to 99%. Lincomycin impurity B can be used as an analytical standard for HPLC analysis and as an API impurity in drug development. It also may be used as a research metabolite or pharmacopoeia reference material.

O-Desethyl Dapagliflozin is a white powder that is a synthetic drug product. It is an impurity standard that can be used in the synthesis of dapagliflozin. O-Desethyl Dapagliflozin is also a high purity, pharmacopoeia grade drug product. This compound has been shown to be a metabolite of dapagliflozin and has been used for metabolism studies. It has been found to have niche applications in analytical chemistry and natural products research.

Please enquire for more information about Gossypol-d2 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Dmab-anabaseine dihydrochloride is an analytical reference standard for HPLC. It has been used as an impurity standard in the production of drugs and drug products. Dmab-anabaseine dihydrochloride is an impurity that can be found in the synthesis of Metabolite. The purity of this compound is 99% with a CAS number of 154149-38-9. Dmab-anabaseine dihydrochloride is natural or synthetic and it does not have any pharmacopoeia listings. Custom synthesis and research and development are some other uses for this product.

Fluticasone Furoate Impurity L is an impurity of Fluticasone Furoate, a drug product. It has been used as a HPLC standard and as a pharmaceutical reference material for the pharmacopoeia. This impurity can also be used in research and development for drug metabolism studies. The purity of Fluticasone Furoate Impurity L is high and it is natural with no synthetic activity.

Vinorelbine N'B-oxide is a drug product that is used as an analytical or impurity standard. It is a natural product and its chemical structure has been determined by HPLC. Vinorelbine N'B-oxide is metabolized in vivo to vinorelbine and N'-desmethylvinorelbine, which are metabolites of vinorelbine. It has been shown to be useful for metabolism studies.

Please enquire for more information about α-Glycerophosphoric acid dicyclohexylammonium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

5-[4’-Carboxy-(1,1’-biphenyl)-2-yl]-2-triphenylmethyltetrazole is a versatile compound with various applications. It has been found to exhibit steroid-like properties and interacts with dopamine receptors. Additionally, it has shown antiviral activity against certain viruses such as tenofovir and blonanserin.

Diornithine is a medicinal compound that has been identified as an analog of ornithine, a non-essential amino acid found in human urine. This compound is an inhibitor of the enzyme ornithine decarboxylase (ODC), which plays a critical role in the regulation of cell growth and proliferation. Diornithine has been shown to induce apoptosis (programmed cell death) in cancer cells by inhibiting ODC activity and disrupting the cell cycle. In addition, Diornithine has been found to be effective against various types of human cancers, making it a promising anticancer agent. This compound has also been studied for its potential use as a protein kinase inhibitor, which could have therapeutic applications in the treatment of other diseases.

Simotinib is a kinase inhibitor that has shown promising results in the treatment of various types of cancer. It targets specific proteins that are involved in the growth and survival of tumor cells, leading to apoptosis (cell death) and inhibition of cancer cell proliferation. This medicinal compound is an analog of cyclin-dependent kinases inhibitors and has been extensively studied in Chinese patients with lung cancer. Simotinib works by blocking the activity of certain enzymes that promote tumor growth, making it an effective anticancer agent. It has also been found to have potential therapeutic applications in other types of cancer, including breast and prostate cancer. Overall, Simotinib shows great promise as a targeted therapy for cancer treatment.

PBB 154 is a medicinal compound that has shown promising results in the treatment of cancer. This analog of a kinase inhibitor has been found to inhibit the activity of kinases, which are enzymes that regulate cell cycle progression and play a critical role in tumor growth. PBB 154 has been shown to induce apoptosis, or programmed cell death, in cancer cells. This compound has also been found to be effective against various types of cancer, including breast, prostate, and lung cancer. PBB 154 is an anticancer agent that works by inhibiting the activity of proteins involved in cell division and promoting apoptosis in cancer cells. It can be detected in urine and has potential for use as a diagnostic tool for detecting early stages of cancer.

Desmethylnortriptyline is a tricyclic antidepressant drug that has been shown to have anti-inflammatory properties. It inhibits the production of inflammatory cytokines in the intestine, which may be due to its effect on the induction of apoptosis by inhibiting protein synthesis. Desmethylnortriptyline also has a beneficial effect on bowel diseases, such as colitis and ileitis. This drug inhibits the uptake of serotonin in rat brains and can lead to decreased levels of serotonin in the brain and spinal cord, which may be responsible for its clinical response. Desmethylnortriptyline is metabolized by demethylation and deamination. It undergoes oxidative deamination by cytochrome P450 enzymes found in human liver microsomes and isolated heart tissue, generating an inactive product. The drug also undergoes oxidation by uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) to form an active metabolite.

Foxy 5 trifluoroacetic acid is a nanofiber that can be used to create a cancer-fighting drug. It is made of polymers and has been shown to have the ability to absorb electromagnetic fields from all directions. Foxy 5 trifluoroacetic acid is packaged in a small, easy-to-handle container that releases the drug when the package is positioned against the tumor. This drug can be used for colon cancer and colorectal cancer because it targets only cells with efflux proteins, which are proteins that promote cancer cell metastasis. In addition, Foxy 5 trifluoroacetic acid has been shown to be effective against prostate and breast cancers by targeting specific receptors on these cells.

Celosin I is a potent kinase inhibitor and analog that has been shown to have significant anticancer properties. It works by inhibiting the activity of kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. Celosin I has been found to induce apoptosis, or programmed cell death, in cancer cells, making it a promising therapeutic agent for the treatment of various types of tumors. This medicinal compound has been isolated from the urine of Chinese individuals and has been extensively studied for its potential as an anticancer drug. Celosin I is a promising candidate for further development as a cancer therapy due to its high potency and selectivity towards cancer cells.

Clindamycin phosphate EP impurity G is a metabolite of clindamycin that can be found in the urine of patients taking clindamycin. It is a white to off-white crystalline solid with a melting point of about 205°C. Clindamycin phosphate EP impurity G has been used as an analytical reference standard for clindamycin, and it is also used as a synthetic intermediate in the drug development process. The CAS number for this compound is 719-72-4.

3-Dodecenal is a human analog that has been studied for its potential anticancer properties. It has been shown to induce apoptosis, or programmed cell death, in tumor cells. This medicinal compound acts as an inhibitor of protein kinases, which play a crucial role in regulating the cell cycle and are often overactive in cancer cells. 3-Dodecenal has shown promising results in inhibiting cancer cell growth in Chinese hamster ovary cells and may have potential as a natural alternative to traditional cancer treatments. In addition, this compound has been detected in human urine and is believed to have potential health benefits beyond its anticancer properties.

Desotamide B is an analog of saxagliptin, a kinase inhibitor that has shown promising results in the treatment of cancer. It has been found to induce apoptosis, or programmed cell death, in cancer cells while sparing healthy cells. Desotamide B specifically targets kinases and proteins involved in the growth and survival of cancer cells, making it a potential anticancer therapy. This compound has been tested on Chinese hamster ovary cells and human tumor cell lines with positive results. Desotamide B is excreted primarily through urine, indicating its potential for use as a systemic therapy for various types of cancer. Its unique mechanism of action makes it a promising candidate for future cancer treatments.

2-Cyclohexen-1-one is a synthetic drug product that has been used in research and development, as a metabolite, impurity standard and analytical reference material. This compound is also used in pharmacopoeia as an API impurity. The chemical purity of this product is greater than 99%.

Mikimopine is a kinase inhibitor that has shown promising results in the treatment of cancer. It works by inhibiting specific proteins involved in cancer cell growth and survival, leading to apoptosis (cell death) of tumor cells. Mikimopine is an analog of a naturally occurring protein found in human urine and Chinese medicinal herbs. It specifically targets cyclin-dependent kinases, which are enzymes that regulate cell division and proliferation. This drug has shown potent anticancer activity both in vitro and in vivo, making it a promising candidate for further development as an anticancer agent. Its selectivity towards cancer cells makes it a potentially effective therapy with minimal side effects compared to traditional chemotherapy treatments.

4-Carboxy-3-ethoxy)phenyl acetic acid (CPAE) is a fluorescent compound that has been shown to have antidiabetic and luminescence properties. It absorbs light at wavelengths of 340, 405, and 455 nm and emits light at 525 nm. It also absorbs UV light at 310 nm and emits fluorescence at 495 nm. CPAE is formed by the condensation of two molecules of 4-carboxybenzaldehyde with one molecule of ethyl 3-ethoxypropanoate in the presence of a base. The crystals are monoclinic, with space group P2/c and lattice constants a = 12.872(1) Å, b = 7.319(1) Å, c = 17.814(2) Å, β = 98.664(9)°, Z = 2. The molecular weight is 182.24 g/mol and its molecular